Based in Basel, Clinerion is a leading provider of medical data informatics, with over 426 million patients in 10,340 healthcare organisations and trial sites in 24 countries registered on its Patient Explorer Network as of 2022. The Swiss company has now become part of the Citeline family, a Norstella group company specialising in clinical trial intelligence.
Citeline, the world’s most comprehensive provider of real-time R&D intelligence to the pharmaceutical industry, with over 30,000 users, has completed the acquisition of Clinerion. Founded in 2008, Clinerion is a global data technology service company dedicated to accelerating clinical research and medical access to treatments for patients. The Swiss company uses proprietary technologies to analyse patient data from its global network of partner hospitals.
Its platform, Patient Network Explorer, accesses 100% real-time information on aggregated patient populations across institutions and geographies to provide data-driven protocol optimisation, site feasibility evaluation and real-time patient search and identification to match patients to treatments. The solution hence radically improves the efficiency and effectiveness of clinical trial recruitment.
Last year, Clinerion reached 426 million patients in 10,340 healthcare organisations and trial sites in 24 countries. Additionally, the company launched a Federated Machine Learning Platform to enable the training and validation of machine learning (ML) algorithms on its global RWD network. Apart from the contributions to drug development, this platform targets to develop preventive care for patients before they reach a critical stage.
Since October 2022, Citeline (formerly Pharma Intelligence) is a company of Norstella. Comprised of four prominent pharmaceutical solutions providers (Evaluate, MMIT, Panalgo, The Dedham Group and Citeline), Norstella is poised to be one of the world’s largest pharma intelligence solutions providers on the market. The $5 billion global company has more than 1,600 employees across the five brands.
With the integration of Clinerion into Citeline, Clinerion will get access to experts and expertise along the entire clinical intelligence, planning, development and trials process streams, allowing it to continue to develop cutting-edge technologies and expand its real-world data network. Consequently, customers will benefit from the combined expertise, a broader portfolio of products, faster innovation, and enhanced capabilities.
(Press release/RAN)
Please login or sign up to comment.
Commenting guidelines